ITIH1 and rheumatoid arthritis: We discovered that higher plasma MAPK3 levels could reduce the risk of rheumatoid arthritis (RA), while higher plasma ITIH1 levels might increase the risk of bipolar and reduce the risk of chronic ischemic heart disease (Figure 6).